New research uses AI to engineer enzymes with intricate active sites, expanding the possibilities for synthetic biocatalysts.

A research team have recently published their article, "Rationally designed pooled CRISPRi-seq uncovers an inhibitor of bacterial peptidyl-tRNA hydrolase" in Cell Reports. In this study ...

Assessment of cardiovascular (CV) toxicity by providers in advanced prostate cancer (PCa) patients (pts) on novel hormonal therapy (NHT). This is an ASCO Meeting Abstract from the 2025 ASCO ...

This site uses cookies to enhance your user experience. By continuing to use this site you are agreeing to our COOKIE POLICY.